Back to UBS Group AG UBS Group AG

NNNNNNNN
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in ANBIO BIOTECHNOLOGY

UBS Group AG holds 828 shares of NNNN (ANBIO BIOTECHNOLOGY), worth $11,352 as of 2026-Q2. The position was decreased (-86.9% shares).

Current Value

$11,352

Current Shares

828

Total Value Change

-$31,453

Total Shares Change

-4,910

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
828
-86.9%
$11,3520.0%$13.71
0
2026-Q1
Increased
6,339
+122.5%
$162,8490.0%$23.11
25
2025-Q4
Increased
2,849
+196.8%
$85,6690.0%$29.99
24
2025-Q3
Decreased
960
-91.0%
$35,7600.0%$34.02
0
2025-Q2
Increased
10,695
+86.4%
$338,6040.0%$31.21
37
2025-Q1
New
5,738
-
$42,8050.0%$7.55
31

Other major holders of NNNN: GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used